Cargando…

Differentiating the Cognitive Profile of Schizophrenia from That of Alzheimer Disease and Depression in Late Life

BACKGROUND: To compare the cognitive profile of older patients with schizophrenia to those with other neuropsychiatric disorders assessed in a hospital-based memory clinic. METHODS: Demographic, clinical, and cognitive data of all patients referred to the memory clinic at the Centre for Addiction an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ting, Christina, Rajji, Tarek K., Ismail, Zahinoor, Tang-Wai, David F., Apanasiewicz, Nina, Miranda, Dielle, Mamo, David, Mulsant, Benoit H.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853579/ https://www.ncbi.nlm.nih.gov/pubmed/20405043 http://dx.doi.org/10.1371/journal.pone.0010151

Ejemplares similares

Brain-cognition relationships in late-life depression: a systematic review of structural magnetic resonance imaging studies
por: Marawi, Tulip, et al.
Publicado: (2023)

Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias
por: Brown, Eric E., et al.
Publicado: (2020)

Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrity
por: Gerretsen, Philip, et al.
Publicado: (2019)

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy
por: Lissemore, Jennifer I., et al.
Publicado: (2021)

Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer’s Disease
por: Golas, Angela C., et al.
Publicado: (2023)

Canadian Academy of Geriatric Psychiatry Survey of Brief Cognitive Screening Instruments
por: Ismail, Zahinoor, et al.
Publicado: (2013)

Myelin-Associated Glycoprotein Gene and Brain Morphometry in Schizophrenia
por: Felsky, Daniel, et al.
Publicado: (2012)

Exploratory genome-wide analyses of cortical inhibition, facilitation, and plasticity in late-life depression
por: Wathra, Rafae A., et al.
Publicado: (2023)

Evidence for Structural and Functional Alterations of Frontal-Executive and Corticolimbic Circuits in Late-Life Depression and Relationship to Mild Cognitive Impairment and Dementia: A Systematic Review
por: Rashidi-Ranjbar, Neda, et al.
Publicado: (2020)

Theta-Gamma Coupling and Working Memory in Alzheimer’s Dementia and Mild Cognitive Impairment
por: Goodman, Michelle S., et al.
Publicado: (2018)

Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review
por: Gough, Nicole, et al.
Publicado: (2020)

Pathways linking late-life depression to persistent cognitive impairment and dementia
por: Butters, Meryl A., et al.
Publicado: (2008)

Prevalence of mental health outcomes and effects of sex and mood or cognitive comorbidity in older adults during the COVID-19 pandemic
por: Jassal, Simi, et al.
Publicado: (2022)

Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia
por: Azami, Hamed, et al.
Publicado: (2023)

Enhancing Cognition in Older Persons with Depression or Anxiety with a Combination of Mindfulness-Based Stress Reduction (MBSR) and Transcranial Direct Current Stimulation (tDCS): Results of a Pilot Randomized Clinical Trial
por: Brooks, Heather, et al.
Publicado: (2021)

Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
por: Creese, Byron, et al.
Publicado: (2023)

Magnetic Seizure Therapy for Suicidality in Treatment-Resistant Depression
por: Weissman, Cory R., et al.
Publicado: (2020)

Neurexin-1 and Frontal Lobe White Matter: An Overlapping Intermediate Phenotype for Schizophrenia and Autism Spectrum Disorders
por: Voineskos, Aristotle N., et al.
Publicado: (2011)

Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression
por: Sun, Yinming, et al.
Publicado: (2018)

Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults
por: Diniz, Breno S., et al.
Publicado: (2021)

Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia
por: Davies, Simon JC, et al.
Publicado: (2018)

Superior memory performance in healthy individuals with subclinical psychotic symptoms but without genetic load for schizophrenia
por: Gagnon, G., et al.
Publicado: (2018)

Effectively Caring for Individuals With Behavioral and Psychological Symptoms of Dementia During the COVID-19 Pandemic
por: Keng, Alvin, et al.
Publicado: (2020)

Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms
por: McGirr, Alexander, et al.
Publicado: (2022)

Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
por: Stogios, Nicolette, et al.
Publicado: (2021)

A cross-sectional study of cognitive performance in bipolar disorder across the lifespan: the cog-BD project
por: Jones, Brett D. M., et al.
Publicado: (2023)

Mid to late‐life scores of depression in the cognitively healthy are associated with cognitive status and Alzheimer's disease pathology at death
por: Robinson, Andrew C., et al.
Publicado: (2020)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

Incomplete response in late-life depression: getting to remission
por: Lenze, Eric J., et al.
Publicado: (2008)

Comparing the distribution of neuropsychiatric symptoms among individuals with depression and mild cognitive impairment
por: Keng, A., et al.
Publicado: (2023)

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease
por: Creese, Byron, et al.
Publicado: (2022)

Recruiting for a randomized clinical trial for late-life depression during COVID-19: outcomes of provider referrals vs. Facebook self-referrals
por: Ainsworth, Nicholas, et al.
Publicado: (2023)

Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
por: Creese, Byron, et al.
Publicado: (2021)

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease
por: Liu, Celina S., et al.
Publicado: (2020)

A Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain Stimulation
por: Bhandari, Apoorva, et al.
Publicado: (2016)

S175. AMOTIVATION IS ASSOCIATED WITH SMALLER VENTRAL STRIATUM VOLUMES IN OLDER PATIENTS WITH SCHIZOPHRENIA
por: Caravaggio, Fernando, et al.
Publicado: (2018)

The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders
por: Kozloff, Nicole, et al.
Publicado: (2020)

Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
por: Ismail, Zahinoor, et al.
Publicado: (2023)

Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study
por: Herold, Christina J., et al.
Publicado: (2020)

Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID‐19
por: Geddes, Maiya R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ku0uaa45pq4shkrueopltlcepn